Amarin (NASDAQ:AMRN) will host a conference call
on Monday, April 13, at 4:30 pm ET to provide preliminary Q1 results
and to update on its operations, including its planned appeal of the
adverse patent related to Vascepa (icosapent ethyl).
Current consensus is a loss/share of ($0.09) on revenue of $129M.
Shares down 1% after hours.
https://seekingalpha.com/news/3559475-amarin-to-announce-preliminary-q1-results-april-13
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.